Moroi Y - Search Results

1

Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan.

Namikawa K, Yamazaki N, Nakai Y, Ihn H, Tomita Y, Uhara H, Takenouchi T, Kiyohara Y, Moroi Y, Yamamoto Y, Otsuka F, Kamiya H, Iizuka H, Hatta N, Kadono T. Namikawa K, et al. Among authors: moroi y. J Dermatol. 2012 Feb;39(2):130-7. doi: 10.1111/j.1346-8138.2011.01318.x. Epub 2011 Sep 28. J Dermatol. 2012. PMID: 21950448

2

Phase II study of i.v. interferon-gamma in Japanese patients with mycosis fungoides.

Sugaya M, Tokura Y, Hamada T, Tsuboi R, Moroi Y, Nakahara T, Amano M, Ishida S, Watanabe D, Tani M, Ihn H, Aoi J, Iwatsuki K. Sugaya M, et al. Among authors: moroi y. J Dermatol. 2014 Jan;41(1):50-6. doi: 10.1111/1346-8138.12341. Epub 2013 Dec 20. J Dermatol. 2014. PMID: 24354781 Clinical Trial.

3

Epidemiology of cutaneous tuberculosis in Japan: a retrospective study from 1906 to 2002.

Hamada M, Urabe K, Moroi Y, Miyazaki M, Furue M. Hamada M, et al. Among authors: moroi y. Int J Dermatol. 2004 Oct;43(10):727-31. doi: 10.1111/j.1365-4632.2004.02238.x. Int J Dermatol. 2004. PMID: 15485528

4

The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.

Ito T, Moroi Y, Oba J, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Furue M. Ito T, et al. Among authors: moroi y. Melanoma Res. 2012 Feb;22(1):38-44. doi: 10.1097/CMR.0b013e32834dcfdf. Melanoma Res. 2012. PMID: 22108607

5

Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.

Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, Uchi H, Miyazaki S, Abe T, Hagihara A, Moroi Y, Furue M. Oba J, et al. Among authors: moroi y. J Am Acad Dermatol. 2011 Dec;65(6):1152-60. doi: 10.1016/j.jaad.2010.10.019. Epub 2011 Jun 23. J Am Acad Dermatol. 2011. PMID: 21700362

6

Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival.

Oba J, Nakahara T, Abe T, Hagihara A, Moroi Y, Furue M. Oba J, et al. Among authors: moroi y. J Am Acad Dermatol. 2014 May;70(5):954-6. doi: 10.1016/j.jaad.2014.01.880. J Am Acad Dermatol. 2014. PMID: 24742844 No abstract available.

7

Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data.

Moroi Y. Moroi Y. Int J Clin Oncol. 2009 Dec;14(6):485-9. doi: 10.1007/s10147-009-0942-z. Epub 2009 Dec 5. Int J Clin Oncol. 2009. PMID: 19967482 Review.

8

Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.

Chen SY, Takeuchi S, Moroi Y, Hayashida S, Kido M, Uchi H, Takahara M, Uenotsuchi T, Tu YT, Urabe K, Furue M. Chen SY, et al. Among authors: moroi y. Int J Dermatol. 2008 Jun;47(6):562-6. doi: 10.1111/j.1365-4632.2008.03643.x. Int J Dermatol. 2008. PMID: 18477144

9

[Sentinel lymph node biopsy for melanoma].

Ito T, Nakahara T, Moroi Y. Ito T, et al. Among authors: moroi y. Gan To Kagaku Ryoho. 2010 Apr;37(4):625-8. Gan To Kagaku Ryoho. 2010. PMID: 20461890 Japanese. No abstract available.

10

A case of nodular cutaneous lupus mucinosis.

Terao H, Moroi Y, Urabe K, Koga T, Furue M. Terao H, et al. Among authors: moroi y. J Dermatol. 2003 Apr;30(4):341-3. doi: 10.1111/j.1346-8138.2003.tb00398.x. J Dermatol. 2003. PMID: 12707473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters